Wong and Australian Community Pharmacy Authority

Link copied
Case Copied 45 min read

Wong and Australian Community Pharmacy Authority [2017] AATA 646 (9 May 2017)

Division:GENERAL DIVISION

File Number:           2016/0899

Re:Shui Su Wong

APPLICANT

AndAustralian Community Pharmacy Authority

RESPONDENT

AndVincent Consentino

JOINED PARTY

DECISION

Tribunal:Deputy President Dr C Kendall
Ms LM Gallagher, Member

Date:9 May 2017

Place:Perth

The recommendation of the Australian Community Pharmacy Authority made on 22 January 2016 (that Mr Wong's application made on 9 November 2015 to supply pharmaceutical benefits from particular premises not be approved) is affirmed.

...........[Sgd].............................................................

Deputy President Dr C Kendall

CATCHWORDS

PHARMACIST – application for approval to supply pharmaceutical benefits at particular premises – review sought in Administrative Appeals Tribunal of recommendation by Australian Community Pharmacy Authority not to approve application – requirement for at least 4 full-time or equivalent prescribing medical practitioners practising not satisfied – decision affirmed

LEGISLATION

National Health Act 1953 (Cth) ss 90, 99K, 99L, 105AD

National Health (Australian Community Pharmacy Authority Rules) Determination 2011

ss 4, 5, 9, 10, 11

Schedule 1 Part 2 – Item 132, Item 136

Schedule 2 – Item 211, Item 212

CASES

Issa and Australian Community Pharmacy Authority [2012] AATA 374

Ranallo v ACPA (2008) 108 ALD 57

St Mary’s Health and Community Services Pty Ltd v Australian Community Pharmacy Authority [2016] AATA 673

SECONDARY MATERIALS

National Health (Australian Community Pharmacy Authority Rules) Determination 2011 –Explanatory Statement

REASONS FOR DECISION

Deputy President Dr C Kendall

9 May 2017

INTRODUCTION

  1. On 12 May 2014, Luigi Sgambelluri and Maria Tindara Sgambelluri (the “Lessor”), Uomo Nominees Pty Ltd (as Trustee of the Wong Family Trust) (the “Lessee”) and Mr Shui Su Wong (as Guarantor) executed an Agreement to Lease at premises located at 53 Uduc Road, Harvey, Western Australia (the “Proposed Premises”).

  2. The Agreement to Lease was subject to, among other things, Uomo Nominees obtaining the necessary approvals to supply pharmaceutical benefits from the Proposed Premises.

  3. On 13 May 2014, a sub-lease of the Proposed Premises was agreed to between the Lessee and Mr Wong. 

  4. On 9 July 2014, the Lessor gave its consent to Mr Wong taking a sublease of the Proposed Premises if and when the Australian Community Pharmacy Authority (the “Authority”) approved Mr Wong’s application to establish a pharmacy at the Proposed Premises, subject to the provisions of the Agreement to Lease.

  5. On 9 November 2015, Mr Wong lodged an application under section 90 of the National Health Act 1953 (Cth) (the “Act”) for approval to supply pharmaceutical benefits from the Proposed Premises. In his application for approval, Mr Wong stated that he sought approval in accordance with the provisions of Item 132, ‘New additional pharmacy (at least 10km)’ of Part 2 of Schedule 1 of the National Health (Australian Community Pharmacy Authority Rules) Determination 2011 (Determination No. PB 65 of 2011) (Cth) (“the Pharmacy Rules”).

  6. In accordance with the procedures set out in the Act, on 12 November 2015 the application was referred to the Authority for assessment and recommendation to the delegate of the Secretary of the Department…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Wong and Australian Community Pharmacy Authority and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2017] AATA 646
Decision Date

CaseChat Overview and Summary

This matter concerned an application by Mr Shui Su Wong for approval to supply pharmaceutical benefits at particular premises. The Australian Community Pharmacy Authority (ACPA) had recommended that Mr Wong's application not be approved. Mr Wong sought a review of this recommendation before the Administrative Appeals Tribunal (AAT). The AAT considered evidence and submissions from Mr Wong, the ACPA, and an "Other Party" who was also involved in the proceedings.

The primary legal issue before the Tribunal was whether the requirement under Item 132, 2(a) of the Pharmacy Rules, stipulating the practice of at least four full-time equivalent prescribing medical practitioners, had been satisfied. The Tribunal noted that if this requirement was not met, Mr Wong's application would fail, and it would not be necessary to consider the secondary requirement relating to the gross leasable area of any supermarkets under Item 132, 2(b). A preliminary issue also arose regarding the admissibility of additional evidence provided by Mr Wong that had not been before the ACPA during its initial decision-making process.

The Tribunal addressed the preliminary issue by allowing Mr Wong to present additional evidence, subject to the Other Party having the opportunity to test it and respond. The Tribunal reasoned that this approach would ensure procedural fairness and allow for a comprehensive review. Crucially, the Tribunal found that the evidence presented did not satisfy the requirement of having at least four full-time equivalent prescribing medical practitioners practising in the relevant area. Consequently, the Tribunal concluded that Mr Wong's application failed on this ground.

As the Tribunal determined that the primary requirement under Item 132, 2(a) was not met, it did not proceed to consider the issue of the gross leasable area of supermarkets. The Tribunal affirmed the ACPA's recommendation of 22 January 2016 that Mr Wong's application be not approved.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

As the Tribunal has concluded below that the requirement in Item 132, 2(a) (in relation to the equivalent of 4 full-time prescribing medical practitioners practising) has not been met, the Tribunal has not addressed the legislation, facts and issues relevant to Item 132, 2(b) of the Pharmacy Rules (relating to the gross leasable area). It is not required to do so.EVIDENCE This matter was heard in Perth over three days from 13 to 15 February 2017. The parties were represented as follows:·Mr Shui Su Wong (as Applicant) was represented by counsel, Mr Favell. Mr Favell was instructed by Mr Fordham.·The Australian Community Pharmacy Authority (as Respondent) was represented by counsel, Mr Dean, from the Australian Government Solicitor.·Mr Consentino (as the Other Party) was represented by counsel, Mr Hoyne. Mr Hoyne was instructed by Ms Mihulka. The Tribunal thanks Mr Favell, Mr Hoyne and Mr Dean and their instructors for their invaluable assistance with this matter. The legislation relevant to pharmaceutical registrations is complex and the procedures it requires from both the Tribunal and advocates can prove frustrating. The Tribunal acknowledges the clarity of the submissions (verbally and in writing) by all lawyers in this proceeding and thanks them for their invaluable assistance in relation to the jurisprudence, facts and issues before it. The Tribunal received the following evidence:·Statement of Mr Heath Fisher dated 8 February 2017 (A1)·Applicant’s Statement of Agreed Facts dated 13 February 2017 (A2)·Statement of Mr Brian Hotker dated 27 June 2016 (A3)·Lease details (A4)·Photographs of supermarket and surrounding areas (A5)·Statement of Mr Luigi Sgambelluri dated 4 July 2016 (A6)·Shire of Harvey District Planning Scheme No. 1 (A7)·Statement of Dr Shashi Patel dated 14 February 2017 (A8)·Statement of Ms Kylie Wilson dated 23 June 2016 (A9)·Statement of Ms Kylie Wilson dated 13 February 2017 (A10)·Updated Annexures A and B to A10 – All Harvey hours by medical practitioners (A11)·Statement of Ms Julie Birch dated 19 September 2016 (A12)·Statement of Ms Deborah Whittle dated 30 June 2016 (A13)·Statement of Ms Deborah Whittle dated 14 February 2017 (A14)·Bundle of documents produced under summons by Thompson Surveying Consultants (O1)·Franchise Agreements – IGA and Cellarbrations (O2)·Photograph of door between liquor store and supermarket (O3)·Photographs (colour images of T document 17.1, pages 303 – 330) (O4)·Photographs (colour images of T document 16.1, pages 272 - 280) (O5)·Public Interest Assessment – Cellarbrations dated 7 December 2015 (O6)·Photographs of carpark and entrance to IGA supermarket (O7)·Photograph of IGA carpark sign (O8)·Statement of Ms Carol Board dated 8 August 2016 (O9)·Statement of Mr Billy Davis dated 31 July 2016 (O10)·Statement of Mr William Davis dated 31 July 2016 (O11)·Statement of Ms Vicki Forgiarni dated 29 July 2016 (O12)·Statement of Mr Mark Holmes dated 30 November 2016 (O13)·Statement of Ms Savannah Italiano dated 3 August 2016 (O14)·Statement of Ms Gillian Matheson dated 9 August 2016 (O15)·Statutory declaration of Ms Vikki O’Dea dated 14 July 2016 (O16)·Statement of Mr Ronald Clarke dated 17 January 2017 (O17)·Bundle of documents produced under summons by BCE Surveying Pty Ltd (O18)·Bundle of documents produced under summons by Harley Dykstra Planning & Survey Solutions (O19)·Statement of Ms Marjory Consentino dated 29 July 2016 (O20)·Statement of Mr Sebastian Bolhuis dated 8 August 2016 (O21)·Statement of Mr Vincent Consentino dated 9 August 2016 (O22)·Photograph of sign for Supa IGA and Kambo’s (O23)·Statement of Mr James Panetta dated 14 September 2016 (O24)·T documents (R1)·Fifth Community Pharmacy Agreement (R2)·Sixth Community Pharmacy Agreement (R3).

Decision

Reasons for decision

In the circumstances, the Tribunal is not required to (nor will it) determine the issue of whether, on the day of Mr Wong’s application to the Authority and on the day on which the application was considered by the Tribunal, there were one or 2 supermarkets which occupied a combined total gross leasable area of at least 2500 m2 (as per Item 132, 2(b) of the Pharmacy Rules).DECISION For the reasons outlined above, the recommendation of the Authority made on 22 January 2016 (that Mr Wong’s application made on 9 November 2015 to supply pharmaceutical benefits from particular premises not be approved) is affirmed.

Ratio Decidendi

Legal Principle Established

The Tribunal accepts that the medical practitioners relevant to the issues before it satisfy these requirements. CONSIDERATIONPreliminary matter – Additional evidence to be considered by the Tribunal Mr Wong asked that the Tribunal determine, as a preliminary issue on the review application, the question as to whether, having regard to section 9 of the Pharmacy Rules, the Tribunal could receive from him and consider for the review additional evidence that was not before the Authority at the time when the Authority made the decision under review. With regard to the meaning of subsection 9(b) of the Pharmacy Rules in its application to the Tribunal, the Tribunal in Issa and Australian Community Pharmacy Authority [2012] AATA 374 stated its opinion at [32]:“…an applicant does not have an unrestricted ability to introduce on a review hearing material that was not in the initial application. It is just that, in the ordinary course of events, there will necessarily be quite some lapse of time between when the application is made initially and when the tribunal comes to consider the matter on review.” Mr Wong argued that the additional materials addressed relevant matters for the purpose of Item 132 of the Pharmacy Rules. These materials are in Exhibits A1, A4, A10, A11 and A14. Mr Wong also argued oral evidence of Mr Luigi Sgambelluri regarding a car park and the photographs in Exhibit A5 ought to be received from him and considered for the review. The Other Party objected to the additional materials being admitted into evidence either on the basis that the Other Party had not yet had the opportunity to test the evidence or because it did not see their relevance. The Tribunal, in meeting its objective to provide procedural fairness to all parties, had concerns that the Other Party had not had the opportunity to test the additional evidence and prepare any further evidence in response. Also, the Tribunal found it difficult to determine at that stage if the evidence to be heard regarding the additional materials was critical to Mr Wong’s application. However, the Tribunal was unconvinced that any evidence the Other Party needed to produce in response could not be adduced during cross-examination and was reluctant to adjourn the hearing at that stage. In the circumstances, the Tribunal decided to accede to Mr Wong’s request on the basis that once the evidence was heard, the Other Party would have the opportunity to test the evidence and obtain further evidence in response if it considered it necessary. The Tribunal is satisfied that Mr Wong was given every opportunity to provide all relevant evidence to the Tribunal and examine, cross examine and re-examine witnesses accordingly. Whether, on the day of Mr Wong’s application to the Authority and on the day on which the application was considered by the Tribunal, there were at least the equivalent of 4 full-time prescribing medical practitioners practising in Harvey This issue is central to Mr Wong’s application. If he does not satisfy this requirement, his application fails.